EcoDrugPlus

Tyrosine Kinase 2

Ensembl ID : ENSPNYG00000013313
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSPNYG00000016849
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Itk/tsk-Like

Ensembl ID : ENSPNYG00000000148
Gene Symbol: LOC102215010
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSPNYG00000011975
Gene Symbol: LOC102213074
3 Cross references
199 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSPNYG00000003200
Gene Symbol: LOC102200298
3 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSPNYG00000020151
Gene Symbol: LOC102205555
3 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSPNYG00000016098
Gene Symbol: LOC102207561
3 Cross references
191 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSPNYG00000015680
Gene Symbol: LOC102208816
3 Cross references
206 Possible Orthologues:

Uncharacterized Loc102206349

Ensembl ID : ENSPNYG00000018827
Gene Symbol: LOC102206349
2 Cross references
196 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSPNYG00000005499
Gene Symbol: UTS2R
4 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSPNYG00000010938
Gene Symbol: UTRN
2 Cross references
269 Possible Orthologues:

Utrophin-Like

Ensembl ID : ENSPNYG00000011273
Gene Symbol: LOC102208512
2 Cross references
269 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).